Found: 92
Select item for more details and to access through your institution.
Imaging Transgene Expression for Gene Therapy.
- Published in:
- Journal of Pharmacy Practice, 2001, v. 14, n. 5, p. 376, doi. 10.1106/WKLK-N777-76CV-P88N
- By:
- Publication type:
- Article
The pharmacology of second-generation chimeric antigen receptors.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 7, p. 499, doi. 10.1038/nrd4597
- By:
- Publication type:
- Article
CAR T cells: Building on the CD19 paradigm.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 9, p. 2151, doi. 10.1002/eji.202049064
- By:
- Publication type:
- Article
Biology and clinical application of CAR T cells for B cell malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
- Published in:
- Nature Medicine, 2003, v. 9, n. 3, p. 279, doi. 10.1038/nm827
- By:
- Publication type:
- Article
Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy.
- Published in:
- Nucleic Acids Research, 2011, v. 39, n. 11, p. e72, doi. 10.1093/nar/gkr140
- By:
- Publication type:
- Article
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 10, p. 928, doi. 10.1038/nbt.2678
- By:
- Publication type:
- Article
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 1, p. 71, doi. 10.1038/nbt.2459
- By:
- Publication type:
- Article
T-cell therapy at the threshold.
- Published in:
- 2012
- By:
- Publication type:
- Interview
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 1, p. 73, doi. 10.1038/nbt.1717
- By:
- Publication type:
- Article
Corrigendum: Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 4, p. 453, doi. 10.1038/nbt1395
- By:
- Publication type:
- Article
Stem cell–derived erythroid cells mediate long-term systemic protein delivery.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 8, p. 1017, doi. 10.1038/nbt1227
- By:
- Publication type:
- Article
A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 1, p. 89, doi. 10.1038/nbt1176
- By:
- Publication type:
- Article
Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 5, p. 601, doi. 10.1038/nbt1088
- By:
- Publication type:
- Article
The ABCs of artificial antigen presentation.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 4, p. 403, doi. 10.1038/nbt955
- By:
- Publication type:
- Article
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 4, p. 405, doi. 10.1038/nbt805
- By:
- Publication type:
- Article
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 1, p. 70, doi. 10.1038/nbt0102-70
- By:
- Publication type:
- Article
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 4, p. 405, doi. 10.1038/74455
- By:
- Publication type:
- Article
A Genetic Strategy for Single and Combinatorial Analysis of miRNA Function in Mammalian Hematopoietic Stem Cells.
- Published in:
- Stem Cells, 2010, v. 28, n. 2, p. 287, doi. 10.1002/stem.257
- By:
- Publication type:
- Article
Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase.
- Published in:
- Nature Medicine, 2009, v. 15, n. 3, p. 338, doi. 10.1038/nm.1930
- By:
- Publication type:
- Article
T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.
- Published in:
- Nature Medicine, 2007, v. 13, n. 12, p. 1440, doi. 10.1038/nm1676
- By:
- Publication type:
- Article
Early experience using salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. 45, doi. 10.1111/bjh.16541
- By:
- Publication type:
- Article
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in β-thalassemia.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 52, doi. 10.1111/j.1749-6632.2010.05597.x
- By:
- Publication type:
- Article
Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130518
- By:
- Publication type:
- Article
Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0069025
- By:
- Publication type:
- Article
CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061338
- By:
- Publication type:
- Article
An In Vivo Platform for Tumor Biomarker Assessment.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026722
- By:
- Publication type:
- Article
Progress Toward the Genetic Treatment of the β- Thalassemias.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1054, n. 1, p. 78, doi. 10.1196/annals.1345.010
- By:
- Publication type:
- Article
Animal models and molecular imaging tools to investigate lymph node metastases.
- Published in:
- Journal of Molecular Medicine, 2011, v. 89, n. 8, p. 753, doi. 10.1007/s00109-011-0764-0
- By:
- Publication type:
- Article
Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1721, doi. 10.1007/s00262-011-1073-8
- By:
- Publication type:
- Article
Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1509, doi. 10.1007/s00262-011-1103-6
- By:
- Publication type:
- Article
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
- Published in:
- Oncogene, 2002, v. 21, n. 27, p. 4200, doi. 10.1038/sj.onc.1205425
- By:
- Publication type:
- Article
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.
- Published in:
- Nature, 2009, v. 461, n. 7262, p. 402, doi. 10.1038/nature08320
- By:
- Publication type:
- Article
ASGCT and JSGT Joint Position Statement on Human Genomic Editing.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 8, p. 1282, doi. 10.1038/mt.2015.118
- By:
- Publication type:
- Article
Genome Editing Technologies: Defining a Path to Clinic.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 796, doi. 10.1038/mt.2015.54
- By:
- Publication type:
- Article
T-Cell Immunotherapy: Looking Forward.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 9, p. 1564, doi. 10.1038/mt.2014.148
- By:
- Publication type:
- Article
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
- Published in:
- 2016
- By:
- Publication type:
- journal article
CAR therapy: the CD19 paradigm.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3392, doi. 10.1172/JCI80010
- By:
- Publication type:
- Article
Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.
- Published in:
- Molecular Biotechnology, 2000, v. 15, n. 2, p. 133, doi. 10.1385/MB:15:2:133
- By:
- Publication type:
- Article
[<sup>131</sup>I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 9, p. 988, doi. 10.1007/s00259-005-0057-3
- By:
- Publication type:
- Article
CD19 CAR antigen engagement mechanisms and affinity tuning.
- Published in:
- Science Immunology, 2023, v. 8, n. 81, p. 1, doi. 10.1126/sciimmunol.adf1426
- By:
- Publication type:
- Article
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
- Published in:
- International Journal of Cancer, 2005, v. 116, n. 3, p. 415, doi. 10.1002/ijc.21014
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 499, p. 1, doi. 10.1126/scitranslmed.aau5907
- By:
- Publication type:
- Article
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3010162
- By:
- Publication type:
- Article
Phase I trial: CD19-Targeted CAR T-Cells in Patients with Residual CLL Following Initial Purine Analog-Based Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S48, doi. 10.1016/j.clml.2016.07.069
- By:
- Publication type:
- Article
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 4, p. 533, doi. 10.1093/cid/ciy152
- By:
- Publication type:
- Article